Close
FINDING CURES TOGETHER<sup>SM</sup>

12th AACR Conference on The Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved

​Program 

Friday, Sept. 20

Saturday, Sept. 21

Sunday, Sept. 22

Monday, Sept. 23


​Friday, Sept. 20

Welcome and Opening Session
4-5:45 p.m.

Keynote Address
It doesn't have to be this way: What is public health doing to address health equity in cancer?
Lisa C. Richardson, Center for Disease Control and Prevention, Atlanta, Georgia

AACR Distinguished Lectureship on the Science of Cancer Health Disparities
In pursuit of cancer health equity: Cancer disparities research and intervention across the disparities continuum
Steven R. Patierno, Duke University Medical Center, Durham, North Carolina


MICR Council Meet and Greet

5:45-6:45 p.m.


Poster Session A
/ Opening Reception

6:45-8:45 p.m.

Top of page


Saturday, Sept. 21

Breakfast with Professional Networking Roundtables
8-8:55 a.m.

Plenary Session 1: Cancer Health Disparities - Using Science to Inform Tobacco Policy
Session Chairs: John M. Carethers, University of Michigan, Ann Arbor, Michigan, and Electra D. Paskett, Ohio State University Comprehensive Cancer Center, Columbus, Ohio
9-10:30 a.m.

Science to policy for a ban on the sale of menthol and flavored tobacco products: The San Francisco cancer initiative (SF CAN)
Robert A. Hiatt, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California

Title to be announced
Brian A. King, Center for Disease Control and Prevention, Atlanta Georgia

Susceptibility to tobacco use by diverse youth
Eliseo J. Pérez-Stable, National Institute on Minority Health and Health Disparities, Bethesda, Maryland


Break
10:30-11 a.m.


Plenary Session 2: Cancer Health Disparities in the LGBTQ Community
Session Chairs: Madina Agénor, Tufts University, Medford, Massachusetts, and Liz Margolies, National LGBT Cancer Network, New York, New York
11 a.m.-12:30 p.m.

What do we know about sexual minorities and cancer and where do we go from here?
Charles Kamen, University of Rochester, Rochester, New York

Cancer prevention in the LGBTQ community: Preventing cervical cancer among diverse sexual minority U.S. women
Madina Agénor, Tufts University, Medford, Massachusetts

Cancer survivorship among sexual minority people: Health, interventions, and next steps
Jennifer Jabson Tree, University of Tennessee, Knoxville, Tennessee

Health care disparities experienced by LGBTQ patients facing terminal cancer
Shail Maingi, St. Peter’s Health Partners, Troy, New York


MICR Professional Advancement Session / Lunch on Own (for those not attending PAS)
12:30-2 p.m.
The purpose of the Professional Advancement Session is to provide strategies, practical advice and National Cancer Institute (NCI) funding opportunities for investigators seeking research independence. This forum will foster interactive discussions and offer strategies for trainees and early stage investigators (ESIs) to navigate a career in cancer disparities research.

Opening Remarks and Introductions
Sanya A. Springfield, National Cancer Institute, Center to Reduce Cancer Health Disparities, Bethesda, Maryland

The climb: From precipice to pinnacle
LeeAnn Bailey, Center to Reduce Cancer Health Disparities, Bethesda, Maryland

Beginning with the basics: Helpful pointers and tactics
Anil Wali, Center to Reduce Cancer Health Disparities, Bethesda, Maryland

Becoming a community based researcher: Engaging and leveraging your community
Sandra L. San Miguel, Center to Reduce Cancer Health Disparities, Bethesda, Maryland

Bench to bedside and back: Tips, tools and strategies
Tiffany Wallace, Center to Reduce Cancer Health Disparities, Bethesda, Maryland

Clinical career development: The CURE
Nicole McNeil Ford, Center to Reduce Cancer Health Disparities, Bethesda, Maryland

Panel Discussion, Evaluation, and Closing
Sanya A. Springfield, National Cancer Institute, Center to Reduce Cancer Health Disparities, Bethesda, Maryland


Concurrent Sessions 1 & 2
2-3 p.m.

Concurrent Session 1: Border Health: Challenges and Opportunities for for Control of Cancer Disparities
Session Chair: Shobha Srinivasan, National Cancer Institute, Bethesda, Maryland

Border health overview: Challenges and opportunities

Amy Elizondo, National Rural Health Association, Washington, D.C.

Border health Consortium of the Californias
Prisci Quijada, California Department of Public Health, Sarcramento, California
Jesse Nodora, University of California San Diego, San Diego, California

Colorectal cancer mortality along the U.S.-Mexico border
Caitlin Murphy, University of Texas Southwestern Medical Center, Dallas, Texas

Cancer disparities and survivorship challenges facing young Latina women (<50 years) on the U.S.–Mexico border

Rebecca Palacios, New Mexico State University, Las Cruces, New Mexico


Concurrent Session 2: Comprehensive Cancer Prevention Initiatives in Low- and Middle-Income Country Settings: What Does It Take?
Session Chairs: Lisa A. Newman, Weill Cornell Medicine, New York, New York, and Andrea S. Llera, Instituto Leloir, Buenos Aires, Argentina

Introduction of HPV self-collection in Argentina, main results, and lessons

Silvina Arrossi, CEDES - Centro de Estudios de Estado y Sociedad, CABA, Argentina

Colorectal cancer prevention and screening in Nigeria
T. Peter Kingham, Memorial Sloan Kettering Cancer Center, New York, New York

Breast cancer screening opportunities in sub-Saharan Africa

Alice Chong, RAD-AID International, University of California San Diego, San Diego, California


Break
3-3:30 p.m.


Hot Topics in Cancer Health Disparities 1
Session Chairs: Steven R. Patierno, Duke University School of Medicine, Durham, North Carolina, and Renee Reams, Florida A&M University, Tallahassee, Florida
3:30-5:30 p.m.

The four-kallikrein panel discriminates prostate cancer and aggressive disease in a multiethnic population*
Burcu Darst, Keck School of Medicine of University of Southern California, Los Angeles, California

Identification of mechanisms of resistance to enzalutamide treatment using In Vitro castration-resistant prostate cancer models*
Joakin Mori, Tuskegee University, Tuskegee, Alabama

Disaggregation of gastric cancer risk between Asian American subgroups*
Robert Huang, Stanford University School of Medicine, Stanford, California

Understanding outcome disparities in multiple myeloma: A multi-ethnic comparison of clinical characteristics in Hispanics*
Alem Belachew, The University of Texas MD Anderson Cancer Center, Houston, Texas

A meta-analysis of genome-wide association study and eQTL analysis of multiple myeloma among African Americans*
Wendy Cozen, Keck School of Medicine of University of Southern California, Los Angeles, California

Exposure to phthalates and risk of invasive breast cancer: The multiethnic cohort study*
Anna Wu, University of Southern California, Los Angeles, California

Lung cancer incidence and risk factors in never-smoking Asian American, Native Hawaiian, and Pacific Islander women: A multilevel dataset of electronic health record, cancer registry, and environmental data*
Mindy DeRouen, University of California San Francisco, San Francisco, California

Neighborhood-level social determinants impact non-small cell lung cancer aggressive somatic phenotypes*
Loretta Erhunmwunsee, City of Hope, Duarte, California


Poster Session B / Reception
5:30-7:30 p.m.


Meet the Editors of CEBP
5:30-7:30 p.m.
Meet Cancer Epidemiology, Biomarkers & Prevention (CEBP) Deputy Editor Scarlett Lin Gomez, Senior Editors Christopher I. Li and Julie R. Palmer, along with Associate Editor Jing Peng, during Poster Session B on Saturday night. Discuss your research and find out how to publish in CEBP, the AACR’s journal serving the disparities research community, covering population-based research on cancer etiology, prevention, surveillance, and survivorship.


Evening Off / Dinner on Own

7:30 p.m.

Top of page


Sunday, Sept. 22

Breakfast with Professional Networking Roundtables
8-8:55 a.m.

Addressing Advocacy at the Bench: Implementing Change
8-9 a.m.
Populations at risk for health disparities are less likely than other groups to participate in research studies. This gap in research participation threatens to increase health inequities, as cancer research studies drive the development of new and improved treatments.  Researchers and advocates are combating this issue by co-creating patient engagement efforts that promise to increase patient participation in cancer research. This session will highlight case studies of community-based initiatives, developed and implemented by teams of patients and researchers, working together to reduce and eliminate research and health disparities.

Panelist 1: Lola Fashoyin-Aje, U.S. Food and Drug Administration, Silver Spring, Maryland
Panelist 2: Candance Henley, Blue Hat Foundation, Chicago, Illinois, SSP Advocate
Panelist 3: Nynikka Palmer, University of California San Francisco, San Francisco, California
Panelist 4: Jamie Brewer, U.S. Food and Drug Administration, Silver Spring, Maryland

Plenary Session 3: Cancer Health Disparities in California
Session Chairs: Rick A. Kittles, City of Hope, Duarte, California, and Dennis Deapen, Keck School of Medicine of the University of Southern California, Los Angeles, California
9-10:30 a.m.

Overview of cancer and unique disparities among American Indian and Alaska Natives in California
Claradina Soto, Keck School of Medicine of the University of Southern California, Los Angeles, California
Kori Novak, Toiyabe Indian Health Clinic, Bishop, California

Observations and implications from examining cancer incidence rates and trends of ethnic Asian Americans 
Lihua Liu, University of Southern California, Los Angeles, California

The unnecessary epidemic: Skin cancer in Hispanics and what we need to do about it
Myles G. Cockburn, University of Southern California, Los Angeles, California

Title to be announced
Valerie Yerger, University of California San Francisco, San Francisco, California


Break
10:30-11 a.m.


Plenary Session 4: Addressing Multilevel Factors, From Genomics to Environment, in Prostate Cancer Disparities Among African American Men

Session Chairs: Graham Colditz, Washington University School of Medicine, St. Louis, Missouri, and Gary L. Ellison, National Cancer Institute, Bethesda, Maryland

11 a.m.-12:30 p.m.

Genome science in prostate cancer among African American men
John D. Carpten, Keck School of Medicine of the University of Southern California, Los Angeles, California

Social factors and prostate cancer disparities in African American men
Scarlett Lin Gomez, University of California San Francisco, San Francisco, California

A comprehensive and integrated approach to identify factors associated with aggressive prostate cancer in African-Americans: The RESPOND Study
Ann S. Hamilton, Keck School of Medicine of the University of Southern California, Los Angeles, California


Poster Session C / Lunch
12:30-2:30 p.m.


Educational Sessions 1 & 2
2:30-3:30 p.m.

Educational Session 1: Geospatial and Multilevel Analyses Applied to Cancer Health Disparities
Session Chair: Sandi L. Pruitt, University of Texas Southwestern Medical Center, Dallas, Texas

Using cancer registry data for geospatial and disparity research
Recinda Sherman, North American Association of Central Cancer Registries, Springfield, Illinois

Housing discrimination and cancer disparities research: How are key decisions made?

Kirsten Beyer, Medical College of Wisconsin, Milwaukee, Wisconsin

Novel measurement methods in spatial epidemiology research: Methodological challenges and proposed solutions

Dustin T. Duncan, Columbia University Mailman School of Public Health, New York, New York


Educational Session
2: Disparities in Therapeutic Outcomes and Prevalence of Adverse Effects
Session Chair: M. Eileen Dolan, University of Chicago, Chicago, Illinois

Metformin use and pancreatic cancer survival: Are there racial differences?
Adetunji T. Toriola, Washington University School of Medicine, St. Louis, Missouri

Breast tumor microenvironment in black women: A distinct signature of CD8+ T Cell exhaustion

Song Yao, Roswell Park Comprehensive Cancer Center, Buffalo, New York

Disparities in cardiovascular disease incidence in breast cancer survivors

Zaixing Shi, Fred Hutchinson Cancer Research Center, Seattle, Washington

Advocate perspective

Desiree A. H. Walker, SHARE Cancer Support, New York, New York



Concurrent Sessions 3 & 4

3:30-4:30 p.m.

Concurrent Session 3: Cancer Center–Led Community Outreach and Engagement at NCI Cancer Centers
Session Chair: Lourdes Baezconde-Garbanati, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California

Population-level problems require system-level solutions: Using collective impact approaches to solving cancer disparities
Kim Rhoads, University of California San Francisco, San Francisco, California

Collaboration to address cancer health disparities among Asian Americans and Latinos in Orange County, California

Sora Park Tanjasiri, California State University, Irvine, California

Innovative strategies for outreach and engagement to reduce cancer disparities. Working with and for Latinos, African Americans, and other at-risk populations
Lourdes Baezconde-Garbanati


Concurrent Session
4: New Approaches to Omics and Other Big Data
Session Chair: Melissa B. Davis, Weill Cornell Medical College, New York, New York

Molecular characterization of sessile serrated adenoma/polyps: A risk factor for higher colorectal cancer that further associates with endometrial polyps in female African Americans 
Hassan Ashktorab, Howard University, Washington, D.C.

The impact of ancestry on mutational signatures in populations with African ancestry 
Paz Polak, Ichan School of Medicine at Mount Sinai, New York, New York

Precision medicine at Weill Cornell Medicine/New York Presbyterian: Breaking silos, integrating resources, being inclusive
Andrea Sboner, Weill Cornell Medicine, New York, New York


Poster Session D
4:30-6:30 p.m.


Evening Off / Dinner on Own
6:30 p.m.


Top of page



Monday, Sept. 23


Breakfast with Professional Networking Roundtables

8-8:55 a.m.


Hot Topics in Cancer Health Disparities 2
Session Chair: Gerardo Colón-Otero, Mayo Clinic Cancer Center, Jacksonville, Florida, and Julie Dutil, Ponce Health Sciences University, Ponce, Puerto Rico
9-11 a.m.

Racial disparities in health insurance status of U.S. adults with hematologic malignancies in states with and without Medicaid expansion: Analyses from the National Cancer Database, 2007-2016*
Gregory Calip, University of Illinois at Chicago, Chicago, Illinois

Emergency department-mediated cancer diagnosis in the United States*
Caroline Thompson, San Diego State University, San Diego, California

Development of a prostate cancer care and survivorship intervention trial for ethnically diverse Black men*
Folakemi Odedina, University of Florida, Orlando, Florida

Using whole-exome sequencing of archived FFPE tissue to characterize the mutational landscape of prostate cancer in Nigerian men*
Jason White, Tuskegee University, Tuskegee, Alabama

Loss of alpha-catenin expression is associated with race, aggressive disease, and chemoresistance in triple-negative breast cancer*
Rania Bassiouni, University of Southern California, Los Angeles, California

Dietary folate and prostate cancer tumor aggressiveness differences between African Americans and European Americans*
Daniela Ramirez Aguilar, University of Arkansas for Medical Sciences, Little Rock, Arkansas

Intratumoral heterogeneity in Latino gastric adenocarcinomas*
Luis Carvajal Carmona, University of California Davis, Davis, California

Association of renal cell carcinoma subtypes with race/ethnicity and comorbid medical conditions*
Iona Cheng, University of California San Francisco, San Francisco, California


Break
11-11:30 a.m.


Plenary Session 5: Cancer Disparities in Children and AYA
Session Chair: Elizabeth Gage-Bouchard, Roswell Park Comprehensive Cancer Center, Buffalo, New York
11:30 a.m.-1 p.m.

Disparities in AYA Oncology: The role of treatment site
Julie Wolfson, University of Alabama-Birmingham School of Medicine, Birmingham, Alabama

Survival by race and ethnicity in pediatric and adolescent patients with Hodgkin lymphoma: A report from the Children’s Oncology Group
Justine Kahn, Columbia University, New York, New York

What causes the increased risk of acute lymphoblastic leukemia in Latinos?
Adam de Smith, Keck School of Medicine of the University of Southern California, Los Angeles, California

Inspiring hope, help, and healing: The hard work and heart work of cancer survivorship
Jameisha (Meisha) Brown, Texas A&M University, College Station, Texas, Emory Candler School of Theology, Atlanta, Georgia


Plenary Session 6: Disparities in Response to Immunotherapy and the Cancer Immune Profile
Session Chair: Stefan Ambs, National Cancer Institute, Bethesda, Maryland
1-2:30 p.m.

Disparities in liver tumor subtypes are associated with gut microbiome-mediated metabolism
Xin W. Wang, National Cancer Institute, Bethesda, Maryland

Differences in the immune microenvironment of African American and Caucasian triple-negative breast cancer
Lajos Pusztai, Yale Cancer Center, New Haven, Connecticut

Immunological treatment of advanced prostate cancer: Preferential responsiveness in African-Americans
Oliver Sartor, Tulane Cancer Center, New Orleans, Louisiana


Closing Remarks
2:30 p.m.

*Short talk from proffered abstract 

Top of page